These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1023 related articles for article (PubMed ID: 34192610)

  • 21. Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India.
    Patel A; Agarwal R; Rudramurthy SM; Shevkani M; Xess I; Sharma R; Savio J; Sethuraman N; Madan S; Shastri P; Thangaraju D; Marak R; Tadepalli K; Savaj P; Sunavala A; Gupta N; Singhal T; Muthu V; Chakrabarti A;
    Emerg Infect Dis; 2021 Sep; 27(9):2349-2359. PubMed ID: 34087089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rhino-orbital-cerebral mucormycosis: An epidemiological study from a tertiary care referral center in Western India.
    Patel R; Jethva J; Bhagat PR; Prajapati V; Thakkar H; Prajapati K
    Indian J Ophthalmol; 2022 Apr; 70(4):1371-1375. PubMed ID: 35326057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A systematic review on SARS-CoV-2-associated fungal coinfections.
    Soni S; Namdeo Pudake R; Jain U; Chauhan N
    J Med Virol; 2022 Jan; 94(1):99-109. PubMed ID: 34570905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-19-associated mucormycosis in India: Why such an outbreak?
    Pasquier G
    J Mycol Med; 2023 Aug; 33(3):101393. PubMed ID: 37182234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19 and mucormycosis syndemic: double health threat to a collapsing healthcare system in India.
    Rocha ICN; Hasan MM; Goyal S; Patel T; Jain S; Ghosh A; Cedeño TDD
    Trop Med Int Health; 2021 Sep; 26(9):1016-1018. PubMed ID: 34117677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term Outcome of Coronavirus Disease-associated Mucormycosis: 1-year Follow-up Study from India.
    Agrawal P; Singh AP; Chakotiya PS; Kumar V; Gautam A; Kumar D
    J Assoc Physicians India; 2024 Jun; 72(6):44-48. PubMed ID: 38881134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients.
    Bansal SB; Rana A; Babras M; Yadav D; Jha P; Jain M; Sethi SK
    Transpl Infect Dis; 2022 Apr; 24(2):e13777. PubMed ID: 34932870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathological Study of Mucormycosis in COVID-19 Patients: Experience From a Tertiary Care Center in South India.
    Kandasamy S; Muthuraju S; Vasugi A; Chandrasekar M; Murugan R; Inbasekaran P; R P
    Cureus; 2022 Mar; 14(3):e23016. PubMed ID: 35419223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19 and Mucormycosis: A Black Fungus Disaster?
    Chillana S; Mohit Chilana KA
    Indian J Dermatol; 2022; 67(5):535-538. PubMed ID: 36865825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 associated mucormycosis: A Descriptive Multisite Study from India.
    Gupta R; Kesavadev J; Krishnan G; Agarwal S; Saboo B; Shah M; Mittal A; Durani S; Luthra A; Singhal A; Rasheed M; Rao GVS; Tripathi V; Jha A; Ghosh A; Mohan V; Singh AK; Phatak S; Panicker J; Bhadada SK; Joshi S; Pal R; Mithal A; Vikram N; Misra A
    Diabetes Metab Syndr; 2021; 15(6):102322. PubMed ID: 34717135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors influencing mortality in COVID-19-associated mucormycosis: The international ID-IRI study.
    Sahin M; Yilmaz M; Mert A; Naghili B; Ravanbakhsh F; Varshochi M; Darazam IA; Ebrahimi MJ; Moafi M; Tehrani HA; Mahboob A; Rashid N; Khan EA; Hakamifard A; Eser-Karlidag G; Babamahmoodi A; El-Kholy A; Mosawi SH; Albayrak A; Al Ramahi JW; Addepalli SK; Özer Balin Ş; Khan A; Pandya N; Gurbuz E; Sincan G; Azami H; Dumlu R; Khedr R; Ripon RK; Alkan S; Kose Ş; Ceylan B; Erdem H
    Med Mycol; 2024 Jul; 62(7):. PubMed ID: 38914466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aspergillosis and Mucormycosis in COVID-19 Patients: A Systematic Review.
    Afzal S; Nasir M
    J Coll Physicians Surg Pak; 2022 May; 32(5):639-645. PubMed ID: 35546702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Past, Present and Future of COVID-19 Associated Mucormycosis: A Rapid Review.
    Sarfraz Z; Sarfraz A; Jaiswal V; Poudel S; Bano S; Hanif M; Singh Shrestha P; Sarfraz M; Michel G; Cherrez-Ojeda I
    J Prim Care Community Health; 2022; 13():21501319221099476. PubMed ID: 35587142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19-associated mucormycosis: Case report and systematic review.
    Dilek A; Ozaras R; Ozkaya S; Sunbul M; Sen EI; Leblebicioglu H
    Travel Med Infect Dis; 2021; 44():102148. PubMed ID: 34454090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rhino-Orbital Cerebral Mucormycosis in Non-Diabetic Patients with COVID-19.
    Elhamamsy S; Bayer T; Al-Kaffas M; Hatahet S; Grover M; Samdhani S; Nanda A; Gravenstein S
    R I Med J (2013); 2021 Oct; 104(8):19-21. PubMed ID: 34582509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for COVID-19 associated mucormycosis in India: A case control study.
    Patel AK; Bakshi H; Shah K; Patel S; Patel T; Patel K; Patel KK
    Med Mycol; 2022 Jul; 60(7):. PubMed ID: 35709394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Profile of Mucormycosis Patients during Coronavirus Disease 2019 Pandemic: A Retrospective Observational Study.
    Gondane B; Jain SK; Dube S
    J Assoc Physicians India; 2024 Mar; 72(3):27-31. PubMed ID: 38736113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outbreak of Mucormycosis in Coronavirus Disease Patients, Pune, India.
    Joshi S; Telang R; Tambe M; Havaldar R; Sane M; Shaikh A; Roy C; Yathati K; Sonawale S; Borkar R; Magar R; Bhitkar H; Shitole S; Nakate L; Kudrimoti J; Mave V
    Emerg Infect Dis; 2022 Jan; 28(1):1-8. PubMed ID: 34586055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19-associated mucormycosis: Evidence-based critical review of an emerging infection burden during the pandemic's second wave in India.
    Aranjani JM; Manuel A; Abdul Razack HI; Mathew ST
    PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009921. PubMed ID: 34793455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucormycosis as SARS-CoV2 sequelae in kidney transplant recipients: a single-center experience from India.
    Meshram HS; Kute VB; Chauhan S; Dave R; Patel H; Banerjee S; Desai S; Kumar D; Navadiya V; Mishra V
    Int Urol Nephrol; 2022 Jul; 54(7):1693-1703. PubMed ID: 34792722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.